Topic: Ashish Jha

Moderna announced positive trial results for a combined COVID-19 and flu vaccine, aiming for federal approval by 2025. Dr. Ashish Jha appeared on Chris Cuomo's show to promote the shot, dismissing concerns about mRNA by stating it is naturally present in every cell of the body. The hosts criticize the "native ad" style of the reporting and express skepticism about vaccine safety.

Chris Cuomo questioned Dr. Ashish Jha regarding the loss of public trust following pandemic-era mandates and messaging. Jha defended the vaccines as life-saving for the elderly while acknowledging that mandates are no longer necessary. The discussion also touches on the EU securing 40 million avian flu vaccines as a precautionary measure.

Former White House COVID response coordinator Dr. Ashish Jha appeared on the "Today Show" to promote the new COVID vaccine, suggesting it should be viewed as an "annual shot" similar to the flu vaccine. Jha stated it is safe to receive both the flu and COVID shots simultaneously. The segment is criticized as a marketing effort for pharmaceutical companies, noting the price hike from $20 to $120 per dose.

White House COVID-19 advisor Dr. Ashish Jha admitted in a recorded call that few studies show significant benefits from mandatory year-round masking compared to improvements in indoor air quality. Despite this, the US continues to consider new rules for international travelers due to a lack of transparent data from the Chinese government.

White House COVID-19 Response Coordinator Dr. Ashish Jha encouraged Americans to receive both their flu shot and updated COVID-19 booster at the same time. During a press briefing, Jha joked that "God gave us two arms" specifically so people could receive one injection in each arm during the fall vaccination campaign.

White House COVID-19 Response Coordinator Dr. Ashish Jha urged Americans to trust physicians over "random dudes on Twitter" regarding vaccine safety. Jha confirmed the government has purchased 171 million doses of the bivalent vaccine, potentially for use as a primary series pending FDA approval. Observers noted Jha's rapid speaking cadence and apparent nervousness during recent press briefings as Anthony Fauci prepares for retirement.

Dr. Ashish Jha defended ongoing vaccine mandates by citing George Washington's 1777 order to inoculate the Continental Army against smallpox. Jha argued that local institutions and the military have a historical right to mandate health measures to ensure a "healthy fighting force." Critics challenged the comparison, noting the significant differences between 18th-century variolation and modern mRNA technology.

Health officials warned of a significant surge in Respiratory Syncytial Virus (RSV) affecting both children and the elderly. Dr. Ashish Jha dismissed reports of antiviral shortages, stating the U.S. has plenty of Paxlovid and monoclonals for high-risk patients. The discussion noted that hospitals traditionally aim for high occupancy to remain profitable, contradicting the narrative that "full" hospitals are an unusual crisis state.

White House COVID coordinator Dr. Ashish Jha is actively promoting the new bivalent boosters for all Americans over age 12. Meanwhile, reports indicate that Sweden has the lowest excess mortality rate in Europe, and a study suggests 90% of New York COVID patients on ventilators during the initial surge died.

White House COVID-19 Response Coordinator Dr. Ashish Jha announces a shift toward a single annual COVID-19 shot for most Americans, similar to the flu vaccine model. He cautions that this strategy depends on the absence of significant "variant curveballs" that could bypass existing protections.

White House COVID-19 Response Coordinator Dr. Ashish Jha stated that "God gave us two arms" so that people could receive a flu shot in one and a COVID booster in the other. The comment, made during a press briefing, was criticized as sacrilegious and flippant. Jha's cadence was compared to Apple CEO Tim Cook as he urged millions of Americans to get updated vaccinations this fall.

White House COVID-19 Response Coordinator Dr. Ashish Jha stated that the FDA "pushed" the administration to build new bivalent mRNA vaccines. The phrasing of "building" a vaccine rather than developing it is noted as a shift in medical terminology related to mRNA technology and waning immunity.

White House COVID-19 Response Coordinator Dr. Ashish Jha indicated that Americans should expect annual COVID-19 vaccine updates similar to the flu shot. New bivalent vaccines targeting the BA.5 Omicron sub-variant are expected to be available for everyone over age 12. This shift suggests a "reset" of the definition of being fully vaccinated.

President Joe Biden experienced a "rebound" COVID-19 infection after completing a course of Pfizer's antiviral drug, Paxlovid. White House COVID Response Coordinator Dr. Ashish Jha defended the drug on The View, stating its primary purpose is to prevent hospitalization. The segment highlights the heavy marketing of "authorized oral treatments" and the normalization of rebound infections in high-profile patients.

Dr. Ashish Jha addresses questions regarding whether childhood smallpox vaccinations provide protection against the current monkeypox outbreak, stating the data is still being reviewed. The discussion touches on the physical scars left by historical smallpox vaccines and the current uncertainty regarding immunity levels in older populations. The FDA's role in monitoring the spread and developing testing methods is also noted.

Vice President Kamala Harris faced scrutiny after being seen maskless and hugging individuals at a Washington D.C. conference despite being a close contact of the President. White House COVID-19 Response Coordinator Dr. Ashish Jha struggled to explain how her actions aligned with official CDC guidance. The briefing highlights the difficulty officials face when attempting to define "close contact" and "hugging" in a regulatory context.

President Biden appointed Dr. Ashish Jha, Dean of the Brown University School of Public Health, to replace Jeff Zients as the White House COVID-19 Response Coordinator. Dr. Jha emphasizes preparation for future surges and variants while defending the efficacy of current vaccines against the BA.2 subvariant.

The FDA advisory committee held an eight-hour meeting resulting in a recommendation against COVID-19 booster shots for the general population, limiting them instead to those 65 and older or the immunocompromised. Dr. Ashish Jha and other experts noted that the initial two doses remain highly effective at preventing hospitalization for young, healthy individuals.

Dr. Ashish Jha, Dean of the Brown University School of Public Health, appeared on ABC News to discuss the Johnson & Johnson vaccine as a "game changer." The hosts criticize the segment for failing to address the technical differences between mRNA and viral vector vaccines, noting the doctor's advice to simply take whichever shot is available first.